The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Implantable Neurostimulators Market Research Report 2024
Synopsis
An implantable neurostimulator is a surgically placed device about the size of a stopwatch. It delivers mild electrical signals to the epidural space near your spine through one or more thin wires, called leads. A complete implantable neurostimulation system includes several components: Neurostimulator, Leads, Physician’s programmer, Patient’s programmer.
The global Implantable Neurostimulators market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The major players in United States Implantable Neurostimulators market include Medtronic, Boston Scientific, etc. The top 2 players occupy about 60% shares of the whole market. Mid-Atlantic Region and South Atlantic are main markets, they occupy about 40% of the whole market. Spinal Cord Stimulators is the main type, with a share about 55%. Pain is the main application, which holds a share about 55%.
This report aims to provide a comprehensive presentation of the global market for Implantable Neurostimulators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Neurostimulators.
Report Scope
The Implantable Neurostimulators market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Implantable Neurostimulators market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Implantable Neurostimulators manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Boston Scientific
St. Jude Medical
Cyberonics
NeuroPace
Synapse Biomedical
NeuroSigma
ReShape Lifesciences
ElectroCore Medical
Inspire Medical
NEUROS
SPR
IMTHERA
NEVRO
Segment by Type
Deep Brain Stimulators
Spinal Cord Stimulators
Vagal Nerve Stimulators
Sacral Nerve Stimulators
Gastric Stimulators
Others
Segment by Application
Parkinson's Disease
Epilepsy
Pain
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Implantable Neurostimulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Implantable Neurostimulators in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
An implantable neurostimulator is a surgically placed device about the size of a stopwatch. It delivers mild electrical signals to the epidural space near your spine through one or more thin wires, called leads. A complete implantable neurostimulation system includes several components: Neurostimulator, Leads, Physician’s programmer, Patient’s programmer.
The global Implantable Neurostimulators market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The major players in United States Implantable Neurostimulators market include Medtronic, Boston Scientific, etc. The top 2 players occupy about 60% shares of the whole market. Mid-Atlantic Region and South Atlantic are main markets, they occupy about 40% of the whole market. Spinal Cord Stimulators is the main type, with a share about 55%. Pain is the main application, which holds a share about 55%.
This report aims to provide a comprehensive presentation of the global market for Implantable Neurostimulators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Neurostimulators.
Report Scope
The Implantable Neurostimulators market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Implantable Neurostimulators market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Implantable Neurostimulators manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Boston Scientific
St. Jude Medical
Cyberonics
NeuroPace
Synapse Biomedical
NeuroSigma
ReShape Lifesciences
ElectroCore Medical
Inspire Medical
NEUROS
SPR
IMTHERA
NEVRO
Segment by Type
Deep Brain Stimulators
Spinal Cord Stimulators
Vagal Nerve Stimulators
Sacral Nerve Stimulators
Gastric Stimulators
Others
Segment by Application
Parkinson's Disease
Epilepsy
Pain
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Implantable Neurostimulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Implantable Neurostimulators in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Implantable Neurostimulators Market Overview
1.1 Product Overview and Scope of Implantable Neurostimulators
1.2 Implantable Neurostimulators Segment by Type
1.2.1 Global Implantable Neurostimulators Market Value Comparison by Type (2024-2030)
1.2.2 Deep Brain Stimulators
1.2.3 Spinal Cord Stimulators
1.2.4 Vagal Nerve Stimulators
1.2.5 Sacral Nerve Stimulators
1.2.6 Gastric Stimulators
1.2.7 Others
1.3 Implantable Neurostimulators Segment by Application
1.3.1 Global Implantable Neurostimulators Market Value by Application: (2024-2030)
1.3.2 Parkinson's Disease
1.3.3 Epilepsy
1.3.4 Pain
1.3.5 Others
1.4 Global Implantable Neurostimulators Market Size Estimates and Forecasts
1.4.1 Global Implantable Neurostimulators Revenue 2019-2030
1.4.2 Global Implantable Neurostimulators Sales 2019-2030
1.4.3 Global Implantable Neurostimulators Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Implantable Neurostimulators Market Competition by Manufacturers
2.1 Global Implantable Neurostimulators Sales Market Share by Manufacturers (2019-2024)
2.2 Global Implantable Neurostimulators Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Implantable Neurostimulators Average Price by Manufacturers (2019-2024)
2.4 Global Implantable Neurostimulators Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Implantable Neurostimulators, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Implantable Neurostimulators, Product Type & Application
2.7 Implantable Neurostimulators Market Competitive Situation and Trends
2.7.1 Implantable Neurostimulators Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Implantable Neurostimulators Players Market Share by Revenue
2.7.3 Global Implantable Neurostimulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Implantable Neurostimulators Retrospective Market Scenario by Region
3.1 Global Implantable Neurostimulators Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Implantable Neurostimulators Global Implantable Neurostimulators Sales by Region: 2019-2030
3.2.1 Global Implantable Neurostimulators Sales by Region: 2019-2024
3.2.2 Global Implantable Neurostimulators Sales by Region: 2025-2030
3.3 Global Implantable Neurostimulators Global Implantable Neurostimulators Revenue by Region: 2019-2030
3.3.1 Global Implantable Neurostimulators Revenue by Region: 2019-2024
3.3.2 Global Implantable Neurostimulators Revenue by Region: 2025-2030
3.4 North America Implantable Neurostimulators Market Facts & Figures by Country
3.4.1 North America Implantable Neurostimulators Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Implantable Neurostimulators Sales by Country (2019-2030)
3.4.3 North America Implantable Neurostimulators Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Implantable Neurostimulators Market Facts & Figures by Country
3.5.1 Europe Implantable Neurostimulators Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Implantable Neurostimulators Sales by Country (2019-2030)
3.5.3 Europe Implantable Neurostimulators Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Implantable Neurostimulators Market Facts & Figures by Country
3.6.1 Asia Pacific Implantable Neurostimulators Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Implantable Neurostimulators Sales by Country (2019-2030)
3.6.3 Asia Pacific Implantable Neurostimulators Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Implantable Neurostimulators Market Facts & Figures by Country
3.7.1 Latin America Implantable Neurostimulators Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Implantable Neurostimulators Sales by Country (2019-2030)
3.7.3 Latin America Implantable Neurostimulators Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Implantable Neurostimulators Market Facts & Figures by Country
3.8.1 Middle East and Africa Implantable Neurostimulators Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Implantable Neurostimulators Sales by Country (2019-2030)
3.8.3 Middle East and Africa Implantable Neurostimulators Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Implantable Neurostimulators Sales by Type (2019-2030)
4.1.1 Global Implantable Neurostimulators Sales by Type (2019-2024)
4.1.2 Global Implantable Neurostimulators Sales by Type (2025-2030)
4.1.3 Global Implantable Neurostimulators Sales Market Share by Type (2019-2030)
4.2 Global Implantable Neurostimulators Revenue by Type (2019-2030)
4.2.1 Global Implantable Neurostimulators Revenue by Type (2019-2024)
4.2.2 Global Implantable Neurostimulators Revenue by Type (2025-2030)
4.2.3 Global Implantable Neurostimulators Revenue Market Share by Type (2019-2030)
4.3 Global Implantable Neurostimulators Price by Type (2019-2030)
5 Segment by Application
5.1 Global Implantable Neurostimulators Sales by Application (2019-2030)
5.1.1 Global Implantable Neurostimulators Sales by Application (2019-2024)
5.1.2 Global Implantable Neurostimulators Sales by Application (2025-2030)
5.1.3 Global Implantable Neurostimulators Sales Market Share by Application (2019-2030)
5.2 Global Implantable Neurostimulators Revenue by Application (2019-2030)
5.2.1 Global Implantable Neurostimulators Revenue by Application (2019-2024)
5.2.2 Global Implantable Neurostimulators Revenue by Application (2025-2030)
5.2.3 Global Implantable Neurostimulators Revenue Market Share by Application (2019-2030)
5.3 Global Implantable Neurostimulators Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Implantable Neurostimulators Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Implantable Neurostimulators Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Corporation Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Implantable Neurostimulators Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Implantable Neurostimulators Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 St. Jude Medical
6.3.1 St. Jude Medical Corporation Information
6.3.2 St. Jude Medical Description and Business Overview
6.3.3 St. Jude Medical Implantable Neurostimulators Sales, Revenue and Gross Margin (2019-2024)
6.3.4 St. Jude Medical Implantable Neurostimulators Product Portfolio
6.3.5 St. Jude Medical Recent Developments/Updates
6.4 Cyberonics
6.4.1 Cyberonics Corporation Information
6.4.2 Cyberonics Description and Business Overview
6.4.3 Cyberonics Implantable Neurostimulators Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cyberonics Implantable Neurostimulators Product Portfolio
6.4.5 Cyberonics Recent Developments/Updates
6.5 NeuroPace
6.5.1 NeuroPace Corporation Information
6.5.2 NeuroPace Description and Business Overview
6.5.3 NeuroPace Implantable Neurostimulators Sales, Revenue and Gross Margin (2019-2024)
6.5.4 NeuroPace Implantable Neurostimulators Product Portfolio
6.5.5 NeuroPace Recent Developments/Updates
6.6 Synapse Biomedical
6.6.1 Synapse Biomedical Corporation Information
6.6.2 Synapse Biomedical Description and Business Overview
6.6.3 Synapse Biomedical Implantable Neurostimulators Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Synapse Biomedical Implantable Neurostimulators Product Portfolio
6.6.5 Synapse Biomedical Recent Developments/Updates
6.7 NeuroSigma
6.6.1 NeuroSigma Corporation Information
6.6.2 NeuroSigma Description and Business Overview
6.6.3 NeuroSigma Implantable Neurostimulators Sales, Revenue and Gross Margin (2019-2024)
6.4.4 NeuroSigma Implantable Neurostimulators Product Portfolio
6.7.5 NeuroSigma Recent Developments/Updates
6.8 ReShape Lifesciences
6.8.1 ReShape Lifesciences Corporation Information
6.8.2 ReShape Lifesciences Description and Business Overview
6.8.3 ReShape Lifesciences Implantable Neurostimulators Sales, Revenue and Gross Margin (2019-2024)
6.8.4 ReShape Lifesciences Implantable Neurostimulators Product Portfolio
6.8.5 ReShape Lifesciences Recent Developments/Updates
6.9 ElectroCore Medical
6.9.1 ElectroCore Medical Corporation Information
6.9.2 ElectroCore Medical Description and Business Overview
6.9.3 ElectroCore Medical Implantable Neurostimulators Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ElectroCore Medical Implantable Neurostimulators Product Portfolio
6.9.5 ElectroCore Medical Recent Developments/Updates
6.10 Inspire Medical
6.10.1 Inspire Medical Corporation Information
6.10.2 Inspire Medical Description and Business Overview
6.10.3 Inspire Medical Implantable Neurostimulators Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Inspire Medical Implantable Neurostimulators Product Portfolio
6.10.5 Inspire Medical Recent Developments/Updates
6.11 NEUROS
6.11.1 NEUROS Corporation Information
6.11.2 NEUROS Implantable Neurostimulators Description and Business Overview
6.11.3 NEUROS Implantable Neurostimulators Sales, Revenue and Gross Margin (2019-2024)
6.11.4 NEUROS Implantable Neurostimulators Product Portfolio
6.11.5 NEUROS Recent Developments/Updates
6.12 SPR
6.12.1 SPR Corporation Information
6.12.2 SPR Implantable Neurostimulators Description and Business Overview
6.12.3 SPR Implantable Neurostimulators Sales, Revenue and Gross Margin (2019-2024)
6.12.4 SPR Implantable Neurostimulators Product Portfolio
6.12.5 SPR Recent Developments/Updates
6.13 IMTHERA
6.13.1 IMTHERA Corporation Information
6.13.2 IMTHERA Implantable Neurostimulators Description and Business Overview
6.13.3 IMTHERA Implantable Neurostimulators Sales, Revenue and Gross Margin (2019-2024)
6.13.4 IMTHERA Implantable Neurostimulators Product Portfolio
6.13.5 IMTHERA Recent Developments/Updates
6.14 NEVRO
6.14.1 NEVRO Corporation Information
6.14.2 NEVRO Implantable Neurostimulators Description and Business Overview
6.14.3 NEVRO Implantable Neurostimulators Sales, Revenue and Gross Margin (2019-2024)
6.14.4 NEVRO Implantable Neurostimulators Product Portfolio
6.14.5 NEVRO Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Implantable Neurostimulators Industry Chain Analysis
7.2 Implantable Neurostimulators Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Implantable Neurostimulators Production Mode & Process
7.4 Implantable Neurostimulators Sales and Marketing
7.4.1 Implantable Neurostimulators Sales Channels
7.4.2 Implantable Neurostimulators Distributors
7.5 Implantable Neurostimulators Customers
8 Implantable Neurostimulators Market Dynamics
8.1 Implantable Neurostimulators Industry Trends
8.2 Implantable Neurostimulators Market Drivers
8.3 Implantable Neurostimulators Market Challenges
8.4 Implantable Neurostimulators Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
